Navigation Links
Halozyme Reports Second Quarter 2012 Financial Results
Date:8/6/2012

ny dedicated to developing and commercializing innovative products that advance patient care. With a diversified portfolio of enzymes that target the extracellular matrix, the Company's research focuses primarily on a family of human enzymes, known as hyaluronidases, that increase the absorption and dispersion of biologics, drugs and fluids. Halozyme's pipeline addresses therapeutic areas, such as diabetes, oncology and dermatology that have significant unmet medical need. The Company markets Hylenex® recombinant (hyaluronidase human injection) and has partnerships with Roche, Baxter, ViroPharma and Intrexon. Halozyme is headquartered in San Diego, CA. For more information on how we are innovating, please visit our corporate website at www.halozyme.com.

Safe Harbor Statement
In addition to historical information, the statements set forth above include forward-looking statements including, without limitation, statements concerning ours and our collaborators' programs in development, our intention to address the concerns raised in the complete response letter for HyQ, the anticipated regulatory status of these programs in development, anticipated regulatory milestones, Roche's stated intention to present data from the MabThera Phase 3 trial by the end of the year, our anticipated cash burn for 2012  and potential benefits and attributes of our product candidates. These statements involve risk and uncertainties that could cause actual results to differ materially from those in the forward-looking statements. The forward-looking statements are also identified through use of the words "believe," "enable," "may," "will," "could," "intends," "estimate," "anticipate," "plan," "predict," "probable," "potential," "possible," "should," "continue," and other words of similar meaning. Actual results could differ materially from the expectations contained in forward-looking statements as a result of several fa
'/>"/>

SOURCE Halozyme Therapeutics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Halozyme Confirms Baxter Has Received A Complete Response Letter For HyQ BLA
2. Halozymes Ultrafast Insulin Formulations Improved Postprandial Glycemic Control in Patients Living with Type 1 Diabetes: Phase 2 Study Results Presented at ADA 2012
3. Halozyme Therapeutics to Present at the Jefferies 2012 Global Healthcare Conference
4. Halozyme Reports First Quarter 2012 Financial Results
5. Halozyme to Host First Quarter 2012 Financial Results Conference Call
6. Chindex International, Inc. Reports Financial Results for the Second Quarter and First Half of 2012
7. Press Ganey Releases Enhanced Improvement Portal with Customized Performance Reports
8. Isis Reports Financial Results And Highlights For Second Quarter 2012
9. Champions Oncology Reports Resignation Of Director
10. Volcano Corporation Reports 13 Percent Growth In Second Quarter Revenues; FFR Disposable Revenues Increase 38 Percent
11. OncoGenex Pharmaceuticals, Inc. Reports Second Quarter and First-Half 2012 Financial Results and Reviews Clinical Development Highlights for Custirsen and OGX-427
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2015)... According to a new market research report ... Dual-Energy X-ray Absorptiometry (DEXA), Skinfold Calipers, Air Displacement Plethysmography ... to 2019", published by MarketsandMarkets, the global Body Composition ... is estimated to grow to $1,425.7 Million by 2019, ... 2019. Browse 41 market data Tables ...
(Date:7/30/2015)... 2015 Edwards Lifesciences Corporation (NYSE: EW ), ... hemodynamic monitoring, today announced that Robert A. Ingram ... "Bob is an ardent champion for innovation in the lifesciences ... him on Edwards, board as we pursue our focused innovation ... CEO.  "Bob has provided a valuable perspective to our board, ...
(Date:7/30/2015)... DIEGO , July 30, 2015 /PRNewswire/ ... it has signed a definitive agreement to ... of non-invasive ventilation and sleep-disordered breathing medical ... clinical, innovation and market reputation in China, combined with ResMed,s global leadership in ... people in China ...
Breaking Medicine Technology:Body Composition Analyzers Market Worth $1,425.7 Million by 2019 2Body Composition Analyzers Market Worth $1,425.7 Million by 2019 3Body Composition Analyzers Market Worth $1,425.7 Million by 2019 4ResMed Invests in High-Growth Chinese Sleep and Respiratory Care Market with Curative Medical 2ResMed Invests in High-Growth Chinese Sleep and Respiratory Care Market with Curative Medical 3
(Date:7/31/2015)... ... July 31, 2015 , ... M3 USA MDLinx.com, source of the Smartest Doc ... Exam Courses. , The additions of Gastroenterology, Pulmonology and Allergy/Immunology round out an ... preparing for the exam easy and painless. MDLinx offers thousands of board-exam style ...
(Date:7/31/2015)... (PRWEB) , ... July 31, 2015 , ... According to ... cosmetic experts gathered to see if they could reach a consensus on the steps ... augmentation and facelifts. Overall, the group reached 90 percent consensus on a series of ...
(Date:7/31/2015)... ... July 31, 2015 , ... Cosmetic ... potential patients alike on various plastic surgery procedures including, but not limited to, ... popular dermatology procedures like Botox and fillers. , Staying up to date ...
(Date:7/31/2015)... ... 31, 2015 , ... Transfinder, a software company based in Schenectady, N.Y., achieved ... percent year-over-year for the first six months ended June 30, 2015 compared with the ... beat last year’s record-revenue mark of $10.4 million. , “We know what our customers ...
(Date:7/31/2015)... ... July 31, 2015 , ... Girl Scouts of Historic Georgia ... Georgia through the Girl Scout "Be a Friend First" program. Representatives from Peach State ... , “Peach State Health Plan and our parent company, Centene Corporation, are dedicated ...
Breaking Medicine News(10 mins):Health News:MDLinx Offers Three New Board Exam Prep Courses - Gastroenterology, Pulmonology and Allergy/Immunology 2Health News:MDLinx Offers Three New Board Exam Prep Courses - Gastroenterology, Pulmonology and Allergy/Immunology 3Health News:Article on Plastic Surgery Consensus Highlights the Duties of Veteran Plastic Surgeons, says Beverly Hills Physicians 2Health News:Article on Plastic Surgery Consensus Highlights the Duties of Veteran Plastic Surgeons, says Beverly Hills Physicians 3Health News:Cosmetic Town: Now Providing Interactive And Vital Medical Knowledge 2Health News:Transfinder Closes First Half of 2015 with Record Revenue 2Health News:Peach State Health Plan Presents $10,000 Check for “Be a Friend First” Anti-Bullying Program to Local Girl Scouts 2
... ... , ... TN (PRWEB) February 3, 2010 -- King Pharmaceuticals, Inc. (NYSE:KG) today launched PainBalance, ... to healthcare professionals and others, helping them provide optimal, appropriate care for all ...
... ... in Proper Context , ... Francisco, CA (PRWEB) February 3, 2010 -- The Medpedia Project today announced Medpedia Clinical Trials, ... that are in process or about to begin. Other online sources already allow for searching ...
... ... ... College of Osteopathic Medicine (NYCOM) and School of Health Professions, in partnership with the Nassau ... campus Sports Complex. The free vaccine will be available for all members of the NYIT ...
... , NORCROSS, ... , U.S. Speedskating  Olympic team sports psychologist and sports psychology instructor for ... Colbert Report ,  yesterday, February 1st, 2010 . , Host ... aired several TV segments highlighting his many attempts to ,make the team,. ...
... found , TUESDAY, Feb. 2 (HealthDay News) -- Extended use ... able to kick the habit and reduces the risk that ... The study included 568 adults who smoked 10 or more ... smokers who used nicotine patches for the entire 24 weeks ...
... NASHVILLE, Tenn. , Feb. 2 Healthcare Realty ... stock cash dividend for the quarter ended December 31, 2009 ... share, is payable on March 4, 2010 to shareholders ... Realty Trust is a real estate investment trust that integrates owning, ...
Cached Medicine News:Health News:King Launches Painbalance: Educational Initiative to Help Reduce the Burden of Pain 2Health News:King Launches Painbalance: Educational Initiative to Help Reduce the Burden of Pain 3Health News:King Launches Painbalance: Educational Initiative to Help Reduce the Burden of Pain 4Health News:Medpedia Launches New Clinical Trial Platform 2Health News:Medpedia Launches New Clinical Trial Platform 3Health News:Medpedia Launches New Clinical Trial Platform 4Health News:Ashworth College Instructor Dr. Nicole Detling Miller Appears on 'Colbert Report' 2Health News:Ashworth College Instructor Dr. Nicole Detling Miller Appears on 'Colbert Report' 3Health News:Ashworth College Instructor Dr. Nicole Detling Miller Appears on 'Colbert Report' 4Health News:Ashworth College Instructor Dr. Nicole Detling Miller Appears on 'Colbert Report' 5Health News:Using Nicotine Patch Longer Boosts Efforts to Quit 2Health News:Healthcare Realty Trust Announces Fourth Quarter Dividend 2
Facilitates one-lung ventilation when using dual lumen endobronchial tubes....
... Double lumen tubes ... ventilation., ,Each ... is packaged with ... adaptors, suction catheters ...
Used for endobronchial blockade of the left or right lung for procedures which require one-lung ventilation. Supplied sterile in peel-open packages. Intended for one-time use....
The Pedia-Trake® is designed to reduce the possibility of over penetration., ,Pedia-Trake® is used to establish an emergency airway in pediatric patients more than one year old....
Medicine Products: